Yike Gao

No ORCID on file · 4 papers in corpus
other 2025
Frontiers in oncology ·doi:10.3389/fonc.2025.1543419

INTRODUCTION: The nuclear receptor TR4 binding protein, TRA16, has been implicated in lung carcinogenesis; however, its broader role across diverse human cancers remains poorly understood. Understanding TRA16's involvement in cancer biology…

observational 2024
Diagnostic pathology ·doi:10.1186/s13000-024-01510-4

BACKGROUND: Ovarian clear cell carcinoma (OCCC), well known for its chemoresistance to platinum-based chemotherapy, exhibited a good response in clinical trials of anti-PD-1/PD-L1 inhibitors. By assessing PD-L1 expression, we sought to dete…

lab-animal 2023
Cell & bioscience ·doi:10.1186/s13578-023-01087-3

The two most prevalent subtypes of epithelial ovarian carcinoma (EOC) are ovarian clear cell carcinoma (OCCC) and high-grade serous ovarian carcinoma (HGSC). Patients with OCCC have a poor prognosis than those with HGSC due to chemoresistan…

observational 2023
Cancer medicine ·doi:10.1002/cam4.6778

AIM: As the second most prevalent subtype of epithelial ovarian cancers, ovarian clear cell carcinoma (OCCC) is known for its chemoresistance to conventional platinum-based therapy. In this work, we examined the tryptophan (Trp) metabolism …